May 1, 1976

A controlled trial of amantadine in drug-induced extrapyramidal disorders

Archives of General Psychiatry
A DiMascioJ E Marder

Abstract

Presently marketed antiparkinsonism drugs are potent anticholinergic agents that, while effective in treating extrapyramidal symptoms (EPS), also are productive of or can exacerbate a number of side effects associated with psychotropic drugs. Some of these include gastrointestinal disturbances, visual difficulties, and tardive dyskinesia. A double-blind study was carried out to assess the efficacy (and adverse effects) of amantadine hydrochloride--an agent without appreciable anticholinergic activity--for the treatment of drug-induced EPS. Amantadine was found to be comparable in effect to benztropine mesylate, but with fewer side effects. The potential role of amantadine may be in the treatment of patients with drug-induced EPS for whom medication with anticholinergic properties is contraindicated.

  • References
  • Citations42

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations42

Citations

Mentioned in this Paper

Antipsychotic Effect
N-Methylbenztropine
Lingual-Facial-Buccal Dyskinesia
Schizophrenia
Amantadine
Extrapyramidal Sign
Amantadine Hydrochloride
Antiparkinson Agents
Adverse Effects
Gastrointestinal Diseases

About this Paper

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.